The Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G mouse model linked to Hypertrophic Cardiomyopathy

BACKGROUND. Hypertrophic cardiomyopathy (HCM) is a genetic cardiovascular disorder, primarily involving mutations in sarcomeric proteins. HCM patients present with hypertrophy, diastolic dysfunction and fibrosis, but there is no specific treatment. The sphringosine-1-phosphate receptor modulator, FT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Heart Fail
Main Authors: Ryba, David M., Warren, Chad M., Karam, Chehade N., Davis, Robert T., Chowdhury, Shamim A. K., Alvarez, Manuel G., McCann, Maximilian, Liew, Chong Wee, Wieczorek, David F., Varga, Peter, Solaro, R. John, Wolska, Beata M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6857720/
https://ncbi.nlm.nih.gov/pubmed/31684756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005835
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados